No Data
No Data
Top 5 Health Care Stocks That May Plunge In March
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicat
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Buys US$13.29 Million in Common Stock
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder RA CAPITAL MANAGEMENT, L.P. purchased 1.4 million shares of Common Stock on Mar 25, 26, 27, 2024 at an average price of $9.48 for a total value of $13.29
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$890.32K in Common Stocks
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Tanimoto Sarina sold 97,610 shares of Common Stocks on Mar 22, 25, 2024 at an average price of $9.1212 for a total value of $890.32K. This transaction in
Buy Rating on ARS Pharmaceuticals Amid Strong Neffy Approval Prospects and Indication Expansion
Ars Pharmaceuticals' Merger May Limit Use of Net Operating Losses, Impacting Future Financials
Express News | CORRECTION: On Thursday March 21, 2024 ARS Pharmaceuticals Reported Q4 EPS $(0.07) Beats $(0.14) Estimate
No Data